MedWatch

GN Hearing launches new product platform

Resound Omnia, a new product platform from GN Hearing, is said to provide a 150% improvement in speech understanding compared to older devices.

Photo: GN / PR

GN Hearing, GN Group’s hearing aid manufacturer, is launching a completely new product platform dubbed Resound Omnia, the company announces in a press release.

The new product generation follows the company’s top product Resound One, which is now around two years old, and improves speech understanding by 150% compared to current hearing aids, says GN.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs